Hyperhomocysteinemia is a known cardiovascular risk factor and a key player in the inflammatory activation of autoimmune diseases. Hashimoto's thyroiditis (HT) is the leading cause of hypothyroidism which, in itself, has been associated with a significant raise of homocysteine (Hcy) levels and increased cardiovascular risk. Our aim was to assess the impact of HT on Hcy levels in patients with acute hypothyroidism.
Hyperhomocysteinemia in acute iatrogenic hypothyroidism. The relevance of thyroid autoimmunity / Cicone, F; Santaguida, M G; My, G; Mancuso, G; Papa, A; Persechino, R; Virili, C; Brusca, N; Tofani, A; Scopinaro, F; Centanni, M. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 1720-8386. - 41:7(2018), pp. 831-837. [10.1007/s40618-017-0811-y]
Hyperhomocysteinemia in acute iatrogenic hypothyroidism. The relevance of thyroid autoimmunity
Cicone, F;My, G;Papa, A;Persechino, R;Virili, C;Brusca, N;Scopinaro, F;Centanni, M
2018
Abstract
Hyperhomocysteinemia is a known cardiovascular risk factor and a key player in the inflammatory activation of autoimmune diseases. Hashimoto's thyroiditis (HT) is the leading cause of hypothyroidism which, in itself, has been associated with a significant raise of homocysteine (Hcy) levels and increased cardiovascular risk. Our aim was to assess the impact of HT on Hcy levels in patients with acute hypothyroidism.| File | Dimensione | Formato | |
|---|---|---|---|
|
Cicone_Hyperhomocysteinemia_2018.pdf
Open Access dal 07/09/2022
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
787.1 kB
Formato
Adobe PDF
|
787.1 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
